Filter
609
Filtered Results: 609
Text search:
Myers,
S.,
et
al.
Featured
Recommendations
62
New Publications
64
Language
Document type
No document type
224
Guidelines
178
Studies & Reports
128
Manuals
37
Fact sheets
18
Strategic & Response Plan
12
Training Material
6
Situation Updates
4
Infographics
1
Videos
1
Countries / Regions
Russia
27
Brazil
23
Latin America and the Carribbean
21
South Africa
20
Global
16
Africa
15
Western and Central Europe
15
Ukraine
13
Germany
12
Eastern Europe
10
India
9
Kenya
8
Mozambique
8
Peru
7
Spain
7
West and Central Africa
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Angola
6
Sierra Leone
5
Zimbabwe
5
Asia
5
East and Southern Africa
5
Vietnam
5
Uganda
4
Zambia
4
Ecuador
4
Lesotho
3
Syria
3
Philippines
3
Guinea-Bissau
3
South–East Asia Region
3
Paraguay
3
France
3
Bolivia
3
Argentina
3
Yemen
3
Indonesia
3
Colombia
2
Chile
2
Nigeria
2
Laos
2
Malawi
2
Guinea
2
Italy
2
Haiti
2
Cambodia
2
Venezuela
2
United Kingdom
2
Portugal
2
Southern Africa
2
Bangladesh
2
Liberia
2
Myanmar / Burma
2
Thailand
1
Mexico
1
Turkey
1
Ghana
1
Benin
1
China
1
Rwanda
1
Burkina Faso
1
Tanzania
1
Saudi Arabia
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Central African Republic
1
Ethiopia
1
Honduras
1
Chad
1
South Sudan
1
Iraq
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
48
Public Health
28
Key Resources
20
Women & Child Health
16
Pharmacy & Technologies
16
Capacity Building
2
Toolboxes
COVID-19
199
Mental Health
80
HIV
74
Planetary Health
38
TB
27
NTDs
25
Disability
18
NCDs
13
Rapid Response
11
Pharmacy
10
Ebola & Marburg
8
Caregiver
8
Conflict
5
Refugee
3
Zika
3
Global Health Education
3
AMR
3
Health Financing Toolbox
2
Specific Hazards
1
Polio
1
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...
Se sabe que las mujeres embarazadas experimentan cambios inmunológicos y fisiológicos que pueden hacerlas más susceptibles a las infecciones respiratorias virales, incluido COVID-19. Varios estudios revelaron que las mujeres embarazadas con diferentes enfermedades resp...
The aim of the SATG was to produce a triage scale for use throughout South Africa. The group was multi-disciplinary and comprised doctors, nurses and paramedics. The result of the SATG’s activities is the South African Triage Scale (SATS), a physiology and symptom based scale which prioritises int...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the ...
Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of emerging infectious diseases or multidrug-resistant organisms (MDRO) within their settings and communities. Therefore, evidence-based infection prevention ...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi...
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag...
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C...
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepared, according to the first annual report from the Global Preparedness Monitoring Board. The WHO and the World Bank convened the independent group after ...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
La presente publicación describe la evidencia científica disponible sobre la precisión diagnóstica de las pruebas rápidas de detección de antígenos para SARS-COV-2. El conocimiento de las pruebas diagnósticas para el coronavirus del síndrome respiratorio agudo grave 2 (SARS-COV-2) sigue evo...
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac...
ObjetivoEl objetivodel documento es servir de guía de actuación para el manejo casos de COVID-19 en atención primaria.3.Recomendaciones generalesSe recomienda la colocación de información visual (carteles, folletos, etc.) en lugares estratégicosde los centros de atenció...
Esta é a primeira edição de orientações sobre estratégias de prevenção e controle de infecção (PCI) para utilizar quando houver suspeita de infecção por um novo coronavírus (2019-nCoV). Foi adaptado do guia da OMS de Prevenção e controle de infecções durante os cuidados de saúde pa...
La presente publicación describe la evidencia científica disponible sobre la efectividad del uso de mascarillas o respiradores en la prevención y control de infecciones respiratorias virales incluido COVID-19 a nivel comunitario y hospitalario. Se identificaron 778 estudios publicados hasta abril...
